Abstract
Cell therapy is a promising method for treatment of hematopoietic disorders, neurodegenerative diseases, diabetes, and tissue loss due to trauma. Some of the major barriers to cell therapy have been partially addressed, including identification of cell populations, in vitro cell proliferation, and strategies for immunosuppression. An unsolved problem is recapitulation of the unique combinations of matrix, growth factor, and cell adhesion cues that distinguish each stem cell microenvironment, and that are critically important for control of progenitor cell differentiation and histogenesis. Here we describe an approach in which cells, synthetic matrix elements, and controlled-release technology are assembled and programmed, before transplantation, to mimic the chemical and physical microenvironment of developing tissue. We demonstrate this approach in animals using a transplantation system that allows control of fetal brain cell survival and differentiation by pre-assembly of neo-tissues containing cells and nerve growth factor (NGF)-releasing synthetic particles.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
Purchase on Springer Link
Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Watt, F.M. & Hogan, B.L.M. Out of eden: stem cells and their niches. Science. 287, 1427–1430 (2000).
Freed, C.R. et al. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N. Engl. J. Med. 8, 710–719 (2001).
Freed, C.R. et al. Survival of implanted fetal dopamine cells and neurological improvement 12 to 46 months after transplantation. N. Engl. J. of Med. 327, 1549 (1992).
Spencer, D.D. et al. Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson's disease. N. Engl. J. Med. 327, 1541–1548 (1992).
Kordower, J.H. et al. Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. N. Engl. J. Med. 332, 1118 (1995).
Philpott, L.M. et al. Neuropsychological functioning following fetal striatal transplantation in Huntington's chorea: three case presentations. Cell Transplant. 6, 203–212 (1997).
Fink, J.S. et al. Porcine xenografts in Parkinson's disease and Huntington's disease patients: preliminary results. Cell Transplant. 9, 273–278 (2000).
Tessier-Lavigne, M. & Goodman, C.S. The molecular biology of axon guidance. Science 274, 1123–1133 (1996).
McDonald, J.W. et al. Transplanted embryonic stem cells survive, differentiate and promote recovery in injured rat spinal cord. Nat. Med. 5, 1410–1412 (1999).
Gage, F.H. et al. Survival and differentiation of adult neuronal progenitor cells transplanted to the adult brain. Proc. Natl. Acad. Sci. USA 92, 11879–11883 (1995).
Snyder, E.Y., Yoon, C., Flax, J.D. & Macklis, J.D. Multipotent neural precursors can differentiate toward replacement of neurons undergoing targeted apoptotic degeneration in adult mouse neocortex. Proc. Natl. Acad. Sci. USA 94, 11663–11668 (1997).
Isacson, O. & Deacon, T. Neural transplantation studies reveal the brain's capacity for continuous reconstruction. Trends Neurosci. 20, 477–482 (1997).
Mezey, E., Chandross, K.J., Harta, G., Maki, R.A. & McKercher, S.R. Turning blood into brain: cells bearing neuronal antigens generated in vivo from bone marrow. Science 290, 1672–1674 (2000).
Brazelton, T.R., Rossi, F.M., Keshet, G.L. & Blau, H.M. From marrow to brain: expression of neuronal phenotypes in adult mice. Science 290, 1672–1674 (2000).
Azizi, S.A., Stokes, D., Augelli, B.J., DiGirolamo, C. & Prockop, D.J. Engraftment and migration of human bone marrow stromal cells in the brains of albino rats—similarity to astrocyte grafts. Proc. Natl. Acad. Sci. USA 95, 3908 (1998).
McKerracher, L. et al. Identification of myelin-associated glycoprotein as a major myelin-derived inhibitor of neurite growth. Neuron 13, 805–811 (1994).
Caroni, P. & Schwab, M.E. Antibody against myelin-associated inhibitor of neurite growth neutralizes nonpermissive substrate properties of CNS white matter. Neuron 1, 85–96 (1988).
McKeon, R.J., Schreiber, R.C., Rudge, J.S. & Silver, J. Reduction of neurite outgrowth in a model of glial scarring following CNS injury is correlated with the expression of inhibitory molecules on reactive astrocytes. J. Neurosci. 11, 3398–3411 (1991).
Davies, S.J.A. et al. Regeneration of adult axons in white matter tracts of the central nervous system. Nature 390, 680–683 (1997).
Horner, P.J. & Gage, F.H. Regenerating the damaged central nervous system. Nature 407, 963–970 (2000).
Huang, D.W., McKerracher, L., Braun, P.E. & David, S. A therapeutic vaccine approach to stimulate axon regeneration in the adult mammalian spinal cord. Neuron 24, 639–647 (1999).
Bregman, B.S. et al. Recovery from spinal cord injury mediated by antibodies to neurite growth inhibitors. Nature 378, 498–501 (1995).
Schnell, L. & Schwab, M.E. Axonal regeneration in the rat spinal cord produced by an antibody against myelin-associated neurite growth inhibitors. Nature 343, 269–272 (1990).
Cai, D., Shen, Y., Bellard, M.D., Tang, S. & Filbin, M.T. Prior exposure to neurotrophins blocks inhibition of axonal regeneration by MAG and myelin via a cAMP-dependent mechanism. Neuron 22, 89–101 (1999).
Dekker, A. & Thal, L. Nerve growth factor increases cortical choline acetyltransferase-positive fiber staining without affecting cortical cholinergic neurons. Brain Res. 601, 329–332 (1993).
Kordower, J.H. et al. The aged monkey basal forebrain: rescue and sprouting of axotomized basal forebrain neurons after grafts of encapsulated cells secreting human nerve growth factor. Proc. Natl. Acad. Sci. USA 91, 10898–10902 (1994).
McAllister, A.K., Katz, L.C. & Lo, D.C. Neurotrophins and synaptic plasticity. Annu. Rev. Neurosci. 22, 295–318 (1999).
Sherwood, N., Lesser, S. & Lo, D. Neurotrophin regulation of ionic currents and cell size depends on cell context. Proc. Natl. Acad. Sci. USA 94, 5917–5922 (1997).
Kruttgen, A., Moller, J., Heymach, J. & Shooter, E. Neurotrophins induce release of neurotrophins by the regulated secretory pathway. Proc. Natl. Acad. Sci. USA 95, 9614–9619 (1998).
Lambiase, A., Rama, P., Bonini, S., Caprioglio, G. & Aloe, L. Topical treatment with nerve growth factor for corneal neurotrophic ulcers. N. Engl. J. Med. 338, 1174–1180 (1998).
Lewin, G.R. & Mendell, L.M. Nerve growth factor and nociception. Trends Neurosci. 16, 353–359 (1993).
Petty, B.G. et al. The effect of systemically administered recombinant human nerve growth factor in healthy human subjects. Ann. Neurol. 36, 244–246 (1994).
Williams, L.R. Hypophagia is induced by intracerebroventricular administration of nerve growth factor. Exp. Neurol. 113, 31–37 (1991).
Hatanaka, H. & Tsukui, H. Differential effects of nerve-growth factor and glioma-conditioned medium on neurons cultured from various regions of fetal rat central nervous system. Dev. Brain Res. 30, 47–56 (1986).
Garofalo, L. & Cuello, A.C. Pharmacological characterization of nerve growth factor and/or monosialoganglioside GM1 effects on cholinergic markers in the adult lesioned brain. J. Pharmacol. Exp. Ther. 272, 527–545 (1995).
Mahoney, M.J. Cell assembly and growth factor delivery: factors enhancing the function of transplanted nervous tissue. PhD Thesis, Cornell University (2000).
Moscona, A.A. Rotation-mediated histogenic aggregation of dissociated cells. A quantifiable approach to cell interactions in vitro. Exp. Cell Res. 22, 455–475 (1961).
Yavin, Z. & Yavin, E. Attachment and culture of dissociated cells from rat cerebral hemispheres on poly-lysine-coated surface. J. Cell Biol. 62, 540–546 (1974).
Miyatani, S. et al. Neural cadherin: role in selective cell–cell adhesion. Science 245, 631–635 (1989).
Alberts, B. et al. Molecular and cellular biology of the cell. (Garland Publishing, New York, NY; 1994).
Hutton, L. & Perez-Polo, J. In vitro glial responses to nerve growth factor. J. Neurosci. Res. 41, 185–196 (1995).
Dai, W., Belt, J. & Saltzman, W.M. Cell-binding peptides conjugated to poly(ethylene glycol) promote neural cell aggregation. Bio/Technology. 12, 797–801 (1994).
Mahoney, M. & Saltzman, W.M. Controlled release of proteins to tissue transplants for the treatment of neurodegenerative disorders. J. Pharm. Sci. 85, 1276–1281 (1996).
Hong, K., Nishiyama, M., Henley, J., Tessier-Lavigne, M. & Poo, M. Calcium signalling in the guidance of nerve growth by netrin-1. Nature 403, 93–98 (2000).
Song, H., Ming, G. & Poo, M. cAMP-induced switching in turning direction of nerve growth cones. Nature 388, 275–279 (1997).
Krewson, C.E. & Saltzman, W.M. Distribution of nerve growth factor following direct delivery to the brain interstitium. Brain Res. 680, 196 (1995).
Nonner, D., Brass, B.J., Barrett, E.F. & Barrett, J.N. Reversibility of nerve growth factor's enhancement of choline acetyltransferase activity in cultured embryonic rat septum. Exp. Neurol. 122, 196–208 (1993).
Luo, D., Woodrow-Mumford, K., Belcheva, N. & Saltzman, W.M. Controlled DNA delivery systems. Pharm. Res. 16, 1299–1307 (1999).
Beaty, C.E. & Saltzman, W.M. Controlled growth factor delivery induces differential neurite outgrowth in three-dimensional cell cultures. J. Controlled Release 24, 15–23 (1993).
Mahoney, M. & Saltzman, W.M. Cultures of cells from fetal rat brain: methods to control composition, morphology, and biochemical activity. Biotechnol. Bioeng. 62, 461–467 (1999).
Mahoney, M. & Saltzman, W.M. Millimeter-scale positioning of a nerve-growth factor source and biological activity in the brain. Proc. Natl. Acad. Sci. USA 96, 4536–4539 (1999).
Acknowledgements
This work was supported by National Aeronautics and Space Administration (NASA) Grant NAG 8-1372 and National Institutes of Health Grant NS-038470. M.J.M. was supported by a grant from the NASA Graduate Student Research Program.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mahoney, M., Saltzman, W. Transplantation of brain cells assembled around a programmable synthetic microenvironment. Nat Biotechnol 19, 934–939 (2001). https://doi.org/10.1038/nbt1001-934
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/nbt1001-934
This article is cited by
-
Neural Differentiation of Human-Induced Pluripotent Stem Cells (hiPSc) on Surface-Modified Nanofibrous Scaffolds Coated with Platelet-Rich Plasma
Neurochemical Research (2022)
-
Localized Induction of Gene Expression in Embryonic Stem Cell Aggregates Using Holographic Optical Tweezers to Create Biochemical Gradients
Regenerative Engineering and Translational Medicine (2020)
-
Extracellular matrix-based materials for regenerative medicine
Nature Reviews Materials (2018)
-
Translational considerations in injectable cell-based therapeutics for neurological applications: concepts, progress and challenges
npj Regenerative Medicine (2017)
-
Development of porous HAp and β-TCP scaffolds by starch consolidation with foaming method and drug-chitosan bilayered scaffold based drug delivery system
Journal of Materials Science: Materials in Medicine (2010)